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31Phosphorus nuclear magnetic resonance (NMR) spectros-
copy, 'H (proton) NMR imaging, and spectroscopy of other
nuclei, especially '9fluorine, 23sodium, and 3carbon have pro-
gressed rapidly to the stage at which clinical interest can be
justified. This has come about through improved magnetic
technology and the availability of high-field spectrometers of 20
and 60 cm bore sufficient to permit examination of human
organs and tissues in vivo. While 'H magnetic resonance
imaging has had its major clinical impact in brain imaging [11,
we have yet to see the widespread application of 31P NMR or
other forms of spectroscopy in medicine. There has been some
limited success in the diagnosis and monitoring of rare meta-
bolic myopathies using 31P NMR [2]. However, in many animal
studies, the kidney has proved useful in practical developments
of the technique. As a consequence, it seems highly likely that
clinical nephrology may be one of the early beneficiaries of the
introduction of whole-body, high-field magnets.
Since reviews in 1981 [3, 4] on NMR in renal physiology and
metabolism, some 40 published reports have related directly to
NMR of the kidney. In this report we summarize the most
recent information which has accrued from 31P NMR spectros-
copy of the kidney and to indicate possible future applications
in medicine and renal biochemistry. In particular, we focus on
the ways in which NMR spectroscopy might assist in under-
standing renal function in health and disease. To avoid repeti-
tion of the principles of an NMR study, readers interested in the
technical aspects should refer to [4, 5] because we intend to give
only a brief introduction of the technique here.
Table I summarizes what we feel represents the significant
literature in NMR related to renal metabolism arranged in terms
of increasing biological complexity. Thus, the work with tissue
extracts is considered before isolated tubules, while whole
intact kidney and the kidney in vivo follow although this was
not the chronological order of the work.
Principles of NMR spectroscopy
Applying a radiofrequency pulse to a population of nuclei
'aligned' in a powerful, homogeneous magnetic field induces a
new orientation of nuclei, which can be observed as a nuclear
magnetic resonance signal, itself of radiofrequency. The fre-
quency used to excite the nuclei is specific for the molecular
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species, for example, the naturally occurring isotope 31P. The
frequency of emission, the signal observed, is measurably
different for each phosphorus nucleus (chemical shift), and
hence distinguishes Pi, phosphocreatine (PCr), ATP (a, f3, and
y), glycerophosphorylcholine, and another as yet unknown
phosphorus compound in the kidney. This chemical shift infor-
mation is the basis of much of the chemical analysis by NMR.
The technique is nondestructive arid can be noninvasive. Chem-
ical shift of Pi itself is a unique measurement of intracellular pH,
probably that of the cytoplasm.
Quantitation of 3tP NMR analysis is inherently straightfor-
ward but involves determination of another magnetic property
of the sample, the spin lattice relaxation time, T,. T, is a
property of great biological interest because it is greatly pro-
longed in tumor tissue. In proton NMR tomography (imaging)
the T property, which is shared by 31P, has been exploited in
identifying and localizing tumors in humans. This application of
T, information is outside the scope of the present discussion.
However, knowledge of T, for Pi and other metabolites permits
accurate quantitation and furthermore opens the way to mea-
surement of reaction rates in living tissues by saturation trans-
fer NMR. Comparison of quantitative 31P NMR with standard
chemical or enzymatic analysis of kidney extracts has been of
great interest [30, 34] and has important lessons for those
applying NMR to other tissues. This review therefore begins
with a discussion of quantitation by NMR in renal extracts.
31P NMR in kidney extracts
ATP has 3-phosphorous NMR signals, but only its /3-phos-
phate is unique to it; the frequencies of the a- and /3-phosphates
of ADP are so close to those of the a- and y-phosphate of ATP,
respectively, as to be indistinguishable in NMR experiments in
vivo (see spectrum of control kidney in Fig. 1). Therefore, it is
the usual practice for ADP (and nicotinamide nucleotides) to be
quantified by subtraction of one peak area from another, that is,
ADP equals y — /3; NAD equals a — y. In control kidneys,
when ATP is 6 moles/g dry wt, ADP was effectively zero (y —
/3 = 0.07 0.14), while chemical extraction reveals 2.5 J.Lmoles
ADP/g dry wt. This discrepancy is exaggerated during renal
ischemia (Fig. I, ischemia spectrum). Ischemia destroys renal
ATP, but ADP is still undetectable by NMR: The enzymatic
assay reveals an increase in [ADPI to 7.2 moles/g dry wt.
When this kidney is extracted into perchloric acid, ADP is
detectable to the extent of 5.4 xmoles/g dry kidney using NMR.
Thus, within the limits of error of the experiment, the two
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Fig. 1. 31Phosphate NMR spectra of kidney in vivo. Spectra were
obtained with a 2-turn solenoid coil surrounding the kidney in an intact,
anesthetized rat, within a 4.2 Tesla superconducting magnet (Oxford
Instruments). Ischemia was produced by ligation of the renal pedicle.
Spectra which were obtained under fully aerobic conditions (—)
and during ischemia (------) have been superimposed. Abbreviations are:
MDP, standard methylene diphosphaonate; AMP!?, unknown peak; Pi,
inorganic phosphate; GPC, glyeerophosphorylcholine; ATP, adenosine
triphosphate (a, /3, and y phosphorus atoms); ADP, adenosine
diphosphate (a and /3 phorphorus atoms); NAD/NADH, all intrarenal
pyridine nucleotides,
may also be present at very low, micromolar concentrations in
the kidney. Because AMP is an important regulator of
phosphofructokinase, there are implications for the regulation
of the rate of renal glycolysis.
An essential prerequisite of 31P NMR in biochemistry is that
its quantitation should have a firm basis. Theory determines
that amplitude of the Fourier transformed (FT) peak will have a
fixed relationship to chemical quantity; this was tested for ATP,
ADP, and Pi in perchioric acid extracts. ATP, ADP, and P1
were assayed by both NMR and currently accepted standard
enzymatic and chemical assays. Methylene diphosphonate
(MDP), the internal standard used for NMR comparisons, was
calibrated against P1 standard solutions. The results agreed well
with errors for each metabolite. Using the 4.2 Tesla
magnet, however, the lowest metabolite concentration which
could be accurately assayed by NMR was 0.1 m. There was a
marked discrepancy in "AMP" determinations: NMR deter-
mined AMP with a chemical shift of 12 ppm exceeded by three
to four times the AMP assayed enzymatically [8]. With better
coil design (Brindle, unpublished observations), it is possible to
discriminate at least two components in this peak which must
be assumed to include a variety of sugar phosphates of similar
chemical shift. In a simple experiment, ischemic kidneys (in
which AMP is known to increase to levels detectable by NMR)
were extracted, assayed enzymatically and by NMR, and then
subjected to progressive enzymatic degradation. AMP was
removed stepwise by the addition of PEP, myokinase, and
pyruvate kinase with a progressive drop in the 12 ppm peak.
Table 1. Summary of published work on renal NMR
PCA extracts
Rat
AMP!?
MOP
'Visible' ADP [6]
Quantitation ATP, ADP, Pi [7]
Identity AMP [8]
Identity of mystery peak [9]
Identity of GPC ('4N NMR) [10]
Observed ADP [4]
pH gradients [11]
Identity of metabolites [12]
Thin film techniques [13]
PCA and effects of PCr [14]
Loss of ATP [15]
Preservation [16]
Loss of ATP (Marshall, Ross, and Smith,
unpublished work)
Loss of ATP [17]
Preservation [17]
Tumour [18]
NAO/NADH
-ATP
cx-ADP
ATP
Intact perfused kidney
Rabbit
Rat
Rat (23Na)
Human
2000 1000 0 —1000 —2000
Tumour
Chemotherapy/specific peak [22]
Intact kidney in vivo
Rat
Intact kidney in vivo
Rat
Human
Canine
extraction methods give identical results [6]. From these results
it may be concluded that ADP must be 'free' to be seen in an
NMR spectrum. Clearly, the concentration of free ADP is finely
controlled in the kidney: Even a threefold rise in intracellular
[ADP], which is in the micromolar range, may control the
adenine-nucleotide translocator, the enzyme which, in turn,
controls the rate of ATP synthesis. By extension, free [AMP]
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Nevertheless, when enzymatically determined AMP has been
removed entirely from the extract, a large peak at 12 ppm
remained—clearly this is not AMP. It should be considered that
this study was only possible with ischemic kidney, because the
amount of AMP present (enzymatically) in normal kidney is
below the limits of detection by NMR. It is likely that in intact
kidney, even less AMP than enzymatically measured would be
observed with NMR, because much of it is likely to be bound.
Thus, the 12 ppm peak observed in spectra of whole kidney, or
extracts of normoxic kidney probably receives no contribution
from AMP and only 10 to 20% from sugar phosphates. Studies
into the nature of the 12 ppm peak of renal extracts are
incomplete [9]; it is a stable, water-soluble compound, of which
more is found in cortex than medulla.
More success has been obtained in identifying glycerophos-
phorylcholine as the constituent of the renal medulla which
appears in all renal spectra from all species of kidney examined
to date [10, 35]. '4N NMR was used to demonstrate that it
contained not only phosphorus but nitrogen, and this makes it
likely to be glycerophosphoryicholine. This is supported by
introducing pure glycerophosphorylcholine into renal extracts
[9]. Ullrich and Pehling [36] isolated and identified this com-
pound in guinea pig papilla and showed that its concentration
may alter in response to water-deprivation. This peak in 31P
NMR spectra of kidney may be useful to study the energetics of
the renal medulla.
For thoroughness, we mention preliminary studies of '3C
NMR in which '3C-1-acetate was added to the medium perfus-
ing rat kidneys. Extracts of both perfusion medium and the
kidney show metabolic interconversion of acetate (Stubbs,
unpublished). More complete and detailed studies such as
reported in the liver [11, 37] will be a potentially useful
application of NMR.
31P NMR in isolated renal tubules
Methods used to oxygenate and stir sufficient renal tubules
for 31P NMR studies were developed by Balaban et a! [10] and
refined by Adler, Shoubridge, and Radda [19]. The special
advantages of renal tubules, biochemical homogeneity, and
their ability to establish transmembrane gradients have been
exploited in these two NMR studies. Ability to obtain viable
renal fragments enabled Balaban et al [10] to detect a hetero-
geneity of intracellular pH between cortex and medulla, and
between medulla and papilla, as reviewed previously [4]. This
finding helps explain the very wide (40 Hz) Pi resonance which
is characteristic of the intact kidney; it is derived from reso-
nances of Pi at a variety of pHs [22]. This method also permitted
the identification of the then 'mystery-peak' of renal spectra
[22, 38], since it is confined to papilla and identical to the
waterproofing substance of Ulirich and Pehling [36]. In addi-
tion, from these separate spectra, it is possible to detect ADP in
outer medulla, possibly in papilla, but not in cortical tubules.
While this may be a species difference (these studies are done in
rabbit), it may also throw light on the nature of ADP binding
which appears to exist in some parts of the kidney and not in
others.
A central issue in renal metabolism for many years has been
the regulation of ammoniagenesis by H Simpson and Hager
[39] stress the importance of dicarboxylic acid transport down a
cytoplasmic:mitochondrial pH gradient, Krebs and Vinay [40]
7.0
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Fig. 2. Transmitochondrial pH gradient in intact renal tubules of the
rabbit. Tubules were incubated under aerobic conditions with radioac-
tive DM0, at various pH. Extra-cellular pH was determined electro-
metrically, cytoplasmic pH from the chemical shift of Pi, and
intramitochondrial pH was calculated from the difference between pH
determined by DM0 distribution and that by 31P NMR.
and Ross and Tannen [41] have attempted to calculate
intramitochondrial pH from the glutamate dehydrogenase equi-
librium. However, using 31P NMR in the perfused kidney [19],
Ackerman et al [221 conclude that intracellular pH changes
were insufficient to account for the changes in ammoniagenesis
and the anticipated alteration in the glutamatae dehydrogenase
equilibrium. Activation of 2-oxoglutarate dehydrogenase by
H1-, rather than altered glutamate dehydrogenase equilibrium
was therefore assumed to be responsible for the metabolic
adaptation to acidosis [42]. A better explanation for the discrep-
ancy in NMR determined pH is that this measures not total
intracellular pH, but pH of the cytoplasmic compartment alone
[7]. Recent studies show that "visible" Pi by NMR represents
only a small fraction of the whole cell Pi, thus, the pH
determinations by NMR from the chemical shift of Pi must refer
only to cell compartments in which Pi is observed with NMR,
viz the cytosol.
Combining 31P NMR techniques with classical DM0 pH
determination in isolated rabbit cortical tubules, Adler,
Shoebridge, and Radda [19] have demonstrated: (1) that NMR
pH applies to the cytosol; (2) that a constant relationship exists
between pH determined with DM0 and by NMR; (3) that the
difference between the results obtained by these two techniques
permits determination of intramitochondrial and cytosolic pH in
the same cells over a wide range of extrarenal pH (Fig. 2). At
physiological external pH, no transmitochondrial gradient was
detectable. In acute "acidosis" with external pH reduced to 6.9
to 7.0, a transmitochondrial pH gradient of 0.5 to 0.6 pH U
(mitochondrion, alkaline) developed. Similar measurements in
renal tubules or an intact rat kidney which adapts better to
acidosis are anxiously awaited.
31P NMR of other transporting epithelia
31P NMR can be an effective means of monitoring energetic
events in bladder and other transporting epithelia which could
be a model for renal tubular function. Various technical im-
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Fig. 3. 31Phosphorus NMR spectra qf perfused rectal gland oft/ic shark (Squalus acanthus). The gland was perfused with phosphate-free saline
within a solenoid coil. Spectra were collected (A) before and (B) during stimulation of the gland to secrete by the addition of cyclic AMP (l0 M)
to the bathing medium. Note the increase in P1 at the expense of both PCr and ATP.
A B
Fig. 4. Hypothermic peifusion (10°C) of inlact human kidney. Partial
recovery of renal metabolic activity was observed using a surface coil
during perfusion of the kidney with standard cold-preservation medium.
Spectrum A represents the normal, Spectrum B the abnormal (not
perfused) pole of the same kidney. The entire kidney was maintained
within the bore of a 20-cm 1.9 Tesla magnet.
provements have been reported [13]. Kokko [12] and Civan et al
[431 reported satisfactory 31P NMR spectra obtained from frog
skin "rolled" into a spectrometer tube. The shark rectal gland,
perfused through its vascular bed, differs from kidney in having
a significant PCr peak, which falls sharply when the chloride
pump is activated by exogenous cyclic AMP [14] (Fig. 3).
31P NMR of ischemic kidney
Largely for reasons of expediency, earlier NMR studies of
intact rat kidney were performed in an in vitro system without
attempts to maintain oxygen delivery. Nevertheless, this crude
method has an important relevance to monitoring viability of
organ storage, and hence, is of interest to the transplant
surgeons. The early 31P NMR experiments in isolated rat
kidneys were concerned with establishing conditions under
which one could follow the depletion of metabolites during
warm and cold ischemia. As expected, ATP is lost almost
totally from 3lp NMR spectra as the excised rat kidney can be
inserted in the NMR spectrometer. To prevent rapid degrada-
tion of tissue metabolites, the rat kidney was flushed with
Perfudex® buffer at 0°C immediately after the clamping of the
renal artery and stored in the same buffer prior to the study [23].
ATP falls to undetectable levels within 30 mm of the onset of
cold ischemia. The accumulated Pi is readily visible and con-
tinues to accumulate; pH falls for 20 to 30 mm. This could be an
assay of various flushing media used in normal organ preserva-
tion, because the fall in pH can be minimized by using a suitable
buffer [44].
Similar approaches were used for kidneys removed from rabbits.
In this model, the changes in ATP and pH were similar to those seen
in isolated rat kidney [161. Preliminary studies indicated that ATP
could be restored by perfusing the kidney with blood from a second
- "supporting" animal [161.
The availability of magnets with a 20 cm bore makes it
possible to extend the method to whole human kidney in vitro.
Human kidneys removed for transplantation and other surgical
indications have been studied [17, 18, 45]. In contrast to earlier
results with rat and rabbit kidneys in which AlP signals
disappear within minutes of the onset of ischemia, the human
kidney retains some ATP for up to 12 hr in the cold; dog kidneys
maintained intermediate ATP concentration. This may be a
reflection of the inverse relationship between 02 consumption
and body size as pointed out by Krebs [46]; high residual 02
consumption would lead to an accelerated ATP-turnover and
hence more rapid disappearance of ATP after arresting blood
supply. This difference should be considered in designing renal
preservation studies and highlights the advantages of the non-
invasive 'P NMR assay for intrarenal pH and ATP concentration.
A significant preservation effect has been observed in the
human kidneys by flushing with a hypertonic citrate solution
prior to cold storage (Fig. 4) . Using °P NMR, this flushing
solution is seen to exert two effects on the kidney. Firstly, ATP
is preserved for a much longer period of time, and the change is
in concert with sugar phosphate (including AMP) and Pi. These
findings were validated by chemical assays of kidneys that were
not used for transplantation. Secondly, the pH1 of citrate-
flushed kidney drops considerably more slowly than the saline-
flushed kidney [44].
Con-elations between the metabolic state of the kidney prior to
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Table 2. Comparison of metabolite content of perfused rat kidneyatransplantation and subsequent graft function were assessed using
early graft function and the need for dialysis in week I after trans-
plantation. In addition to the NMR changes of ATP, the accumula—
tion of Pi relative to the sugar phosphate peak and the degree of
intracellular acidosis provide some prognostic index to post-trans-
plant acute tubular necrosis and the early outcome of the subsequent
transplant in 40 kidneys [17]. However, the results do not show
sufficient differentiation of 'good' from 'bad' kidneys to be useful for
clinical purpose. Nevertheless, it has contributed to a better under-
standing of the effect of warm and cold ischemia in organ preserva-
tion and may provide new impetus to the study of organ preserva-
tion. For example, using NMR the damaged pole of one kidney was
shown unable to regenerate ATP despite adequate perfusion (Fig. 4).
These studies further demonstrate the feasibility of NMR to monitor
metabolic changes in kidneys during preservation.
31P NMR
Enzymatic
assay
% by
NMR P value
ATP 4•7 o8b (4) 4.9 0.3 (15) 95% NS
ADP 0.9 0.7 (4) 3.6 0.3 (15) —25% < 0.01
Pi 2.4 0.3 (4) 8.8 0.6 (19) 27% <0.01
a The number of experiments is in parentheses.
' Value is mmoles/kg weight wt.
Table 3. High energy phosphates and metabolic rate in kidney of
thyrotoxic ratsa
ATP
synthesis
[ATP] [ADPJ [Pu moles/minIg
Thyrotoxicosis(N = 4) 3.6 0.3 0.3 0.1 2.0 0.03 33.2 12.7
Control
(N = 10) 2.1 0.2 0.3 0.1 0.7 0.1 16.1 1.2
P <0.001 NS <0.001 <0.05
In vitro perfusion of isolated kidney whereby nearly normal
renal function and acceptable oxygen delivery can be assured,
has been used in 31P NMR studies. Apart from the technical
achievement of obtaining acceptable 31P spectra of rabbit
kidney by supporting renal blood flow from a second animal,
available data suggest that blood-free perfused kidney produced
'physiological' 31P NMR spectra [16].
Systematic monitoring of intrarenal pH became possible with
31P NMR in 1978 and 1979 [19]. An hypothesis relating equilib-
rium in the mitochondrial glutamate dehydrogenase to in-
creased ammoniagenesis in acidosis was tested using 31P NMR
in the isolated perfused rat kidney. From the equilibrium
equation:
and enzymatic assays of freeze-clamped kidneys, the change in
H in metabolic acidosis can be predicted. Using 31P NMR the
intrarenal pH change during metabolic acidosis was 0.4 pH U,
significantly less than the predicted value of 0.8 pH U. This
discrepancy was not fully understood initially [19], but led to
the subsequent realization that pH by NMR represents cyto-
plasmic pH [7, 11]. Intramitochondrial pH has been determined
subsequently in isolated rabbit tubules by a composite tech-
nique involving NMR and DM0 indicator as described above.
The differential effects of H + and HC03 on renal ammonia-
genesis and urinary acidification have been tested using 31P
NMR in isolated perfused rat kidney [8]. Increased pCO2 to
produce acidosis in the external perfusing medium caused a
rapid drop in tissue pH from 7.2 to 6.7. The changes were
readily reversible when the gas mixture was restored to 5%
CO2. The extent of the pH change was indistinguishable from
that observed in acute metabolic acidosis [19], but there was a
major difference in the extent of urinary acidification. Whereas
urine pH as low as 5.5 can be achieved by the perfused kidney
in metabolic acidosis, it can be lowered to only 6.6 during
respiratory acidosis. Calculation of intrarenal concentrations of
bicarbonate based on pCO2 and the intracellular pH determined
by 31P NMR yields 7 m in metabolic and 37 mM in respiratory
acidosis. This major difference in the transluminal membrane
gradient for bicarbonate can explain the difficulty in generating
an acid urine in respiratory acidosis.
a Perfused kidneys were taken from rats made thyrotoxic for 3-day
injection of thyroxine and examined by continuous quantitative and
saturation transfer NMR. Results are in mmoles/kg wet wt; the meta-
bolic rate was calculated from the transfer of magnetization between
y-ATP and P1 observed during saturation of the y-ATP (see [9]).
Quantitative 31P NMR of isolated perfused kidney (Tables 2
and 3) [7,9]. As discussed in detail already, application of 31P
NMR to the isolated perfused kidney system proved ideal for an
accurate comparison with earlier, enzymatic analyses of renal
metabolites. ATP values were comparable by the two methods,
but the major important differences were observed for both Pi
and ADP. Values obtained by 31P NMR were only 25% of those
obtained by enzymatic or chemical assay (Table 2). The "ex-
tra" Pi observed in extracts could not be due to the breakdown
of PCr during extraction as has been postulated in other tissues,
because virtually no PCr can be found in renal spectra. Fur-
thermore, insignificant amounts of ATP were broken down
during extraction, so that neither the discrepancy in Pi deter-
minations nor that of ADP could arise from this source. The
differences appear to arise from a genuine difference in the
metabolic pools 'observed' by the two methods; classical
biochemical methods presumably determine all of the metabo-
lite, while 31P NMR determination is restricted to that fraction
of the metabolic poo1 which is chemically "free." A number of
important consequences can follow from this suggestion: (1)
intracellular Pi = 0.7 m, hence, discussion of Pi transport
across the luminal membrane should be concerned with a
different transmembrane Pi gradient from that usually assumed;
(2) intracellular ADP is less than 0.2 mM, hence, regulation of
the adenine nucleotide translocase may exist in the intact cell
(with a Km for ADP in the millimolar range), thus controlling
oxidative phosphorylation in the intact kidney; (3) phosphoryl-
ation potential [ATP]/[ADP] x [Pu = 12.2 x l0 M ',a value at
least tenfold higher than that obtained by classical techniques
[7]. Free energy ofhydrolysis of ATP is controlled by this relation-
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ship, so that control of Na* transport in the intact kidney may
differ from the presently offered interpretation.
Thus, when Na-K-ATPase, the major active component of
the Na pump, is considered to be an enzyme of fixed stoichi-
ometry, transporting 3 Na ions per ATP hydrolyzed to ADP,
insufficient energy is available to account for all, or even for the
50 to 70% of active Na transport. The higher phosphorylation
potential now believed to exist in kidney would overcome this
objection. The total energy required for Na transport, calcu-
lated from the Nernst equation, could be met by the energy
derived from the ATP hydrolyzed in the same time. This would
require modification of our view of the Na pump [7] into one in
which a continuously variable energy provision could be har-
nessed to transport Na not in the fixed proportion of 3 Na to
I ATP, but to the extent of free energy available from the
ATPase reaction, which clearly contradicts the widely accepted
model. Further evidence supporting this argument requires
knowledge of the actual rate of ATP turnover in the functioning
kidney. This can be provided by the method of saturation
transfer discussed below.
A TP synthesis and the energy cost of Na transport—
sail/ration transfer NMR (STNiVIR) measurements [7]. One of
the most interesting new developments with P NMR is the
exploration of techniques for the determination of metabolic
reaction rates in an intact tissue or organ. Magnetic labelling of
one reactant is possible; the rate at which this reactant is
converted into another can he observed by the change of
magnetization in the second metabolite. This method, described
as "magnetization transfer" by its inventors, Forsen and Hoff-
man, is more commonly known as saturation transfer" or
STNMR. Saturation (the labelling process) is achieved by
rapid, or continuous pulsing, with a second radiofrequency
source, at the frequency of the chosen metabolic species, which
results in its disappearance from Fourier transform spectra.
Transfer is observed in the usual NMR experiment by quanti-
fying the peak of interest in separate spectra obtained with and
without "saturation." When the saturated species is y-ATP,
and that observed is Pi, the rate determined is the metabolic
rate, ATP-synthesis. Freeman et al [7] systematically devel-
oped and validated this technique for the intact perfused rat
kidney. Remarkably good agreement was obtained with the
renal metabolic rate determined by recording oxygen consump-
tion at the same time. The ATP:oxygen ratio of 2.45 speaks for
the validity of the STNMR measurement of ATP synthesis.
Detailed discussion of the energy costs of Na transport of the
perfused kidney has been presented [71. ATP synthesis of 14
moles/min/g dry vt, only 30 to 50% of which is available, and
net Na transport of 67 pmoles/min/g dry wt found in this study
permit a comparison between Na per ATP and the relative
energy required, 325 kJ/min, that is available from ATP hydrol-
ysis (270 to 400 kJ/min). These authors conclude that only a
pump of the latter type can account for active Na transport in
the kidney.
The metabolic rate of kidney is known to vary with blood
flow and with Na reabsorption, both of which may vary
minute-by-minute in vivo. But a persistent increase in meta-
bolic rate is likely to accompany the metabolic adaptation of
thyrotoxicosis. This formed the basis of a preliminary study [47]
to assess the validity of STNMR in T3-induced thyrotoxicosis.
In the perfused kidney, metabolic rate determined by STNMR
increased from 12.9 4.2 (SE) to 25.6 6.1 in thyrotoxicosis.
Oxygen consumption also doubled in kidneys from thyrotoxic
rats, so that the ATP:oxygen ratio was unaltered in this
metabolic adaptation. The increased metabolic rate might be
linked to the observed increase in intracellular free-Pi (Table 3).
GFR and Na transport increased in the isolated kidneys of
thyrotoxc rats [471 and the energy cost of Na transport and
overall contribution of Na transport to the respiratory rate of
the kidney could be calculated. Because phosphorylation po-
tential was lower in thyrotoxicosis (Table 3), it appears unlikely
that this contributes to the extra Na transport. Instead, a higher
overall metabolic rate, driven possibly by the elevated intracel-
lular Pi, accounts for the extra energy required for the increased
rate of Na transport in thyrotoxicosis: Which comes first is not
clear from this study.
23NCI N1t4R and chemical shift reagents. One published study
exploits the high signal intensity of 23Na to follow the reversible
increase in intracellular [Nat] during episodes of ischemia [21].
Inhibition of Na,K-ATPase by ouabain produced a similar
change. Dysprosium polyphosphate, a shift-reagent [20] which
does not enter the renal cell, altered the chemical shift of
extracellular Na so that two peaks for Na appear in spectra.
Changes in Na and Nae can then be observed at the same
time. The perfused kidney was used in these studies because
dysprosium is toxic to the animal; alternative "shift" reagents
will be required for extension of this interesting study in vivo.
Isolated perfused human kidney
Human studies with P NMR became possible with wide-
bore, high-field magnets. Forearm muscle, lower limb, the brain
of infants (the head small enough to enter a 20-cm bore magnet),
and in the past year, adult brain and adult liver have all
produced the 31P NMR spectra which were anticipated from
preceding animal studies. The human kidney was the first
internal organ subjected to systematic 31P NMR studies [17, 18,
381 and promises a rich seam of novel findings when the
technique is applied in vivo.
The general appearance of 31P NMR spectra of human kidney
is identical to those now so familiar from the rat kidney in vivo
or perfused in vitro. Six principal resonances are observed as
shown in Figure 5. The kidney has an intracellular pH of 7.0 to
7.2. Among the predictable applications of31P NMR to clinical
nephrology are the ability to detect acute ischemic or
hypotensive changes prior to acute tubular necrosis. Reversible
loss of ATP, accumulation of Pi, and tissue acidification have
been demonstrated readily in the blood-perfused human kidney
(Fig. 6). Recovery from acute ischemia is rapid (within 5 mm).
Recovery of renal ATP and Pi to normal is equally rapid after a
period of warm ischemia, cold flushing with renal preservative,
and storage in the cold for 2 hr. However, if storage in the cold
is prolonged for 48 hr before recirculation of blood, recovery of
ATP is both delayed and incomplete. This pattern is familiar to
transplant surgeons and indicates the future usefulness of 31P
NMR in in vivo monitoring of the transplanted kidney.
31P NMR of renal carcinoma. The isolated perfused human
kidney, in which a tumor, either hypernephroma or Wilms'
tumor is present, usually shares a single blood supply, and
thereby establishes a unique control of normal and cancerous
tissue for comparison in NMR studies [18, 38, 451. A number of
interesting features include: (I) If the tumor has a unique
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Fig. 5. Hypernephromu of hu,nan kidney. (Left) The appearance of the kidney after 6 hr of hormothermic perfusion. (Right) 31Phosphorus NMR
spectra obtained with two surface coils within a TMR 32 spectrometer. Upper spectrum represents the normal kidney; lower spectrum represents
the hypernephroma. Note the complete profile of renal metabolites and an additional peak at +4.2 ppm in the renal cell carcinoma. For
identification of peaks see Figure 6.
'phosphate' peak, it is probably indicative of Pi within cells of
highly acidic environment; (2) during hypoxia anaerobic
glycolysis maintains tumor ATP, while as ATP rapidly disap-
pears from the normal pole of the same kidney; (3) omission of
substrate glucose or pyruvate from the perfusing blood leads to
the loss of the unique "tumor" peak and the addition of
pyruvate in high concentration restores the peak. These obser-
vations are consistent with a Pi peak generated during
glycolytic activity in the tumor and not in normal kidney.
Eveihoch et al [48] have observed a similar tumor peak in
mouse osteosarcoma. In one hypernephroma and one Wilms'
tumor, the addition of chemotherapeutic agents to the perfusing
blood dramatically altered the appearance of the tumor peak; in
the hypernephroma it increased three- to fourfold in concentra-
tion at the expense of Alp. If this indicates drug sensitivity of
this normally highly resistant tumor, then application of 31P
NMR to tumor monitoring in vivo has an important place in
oncology in the future.
31P NMR of intact kidney in vivo
Noninvasive study. Thus far, only a single study [271 in the
rat demonstrates the capability of 31P NMR to be an entirely
noninvasive tool for studying the kidney. Using a surface coil
and field profiling ("TMR") [27], the PCr peak of overlying
muscle could be eliminated gradually from spectra until the
characteristic renal spectrum revealed that focusing had oc-
curred. This was confirmed by the loss of ATP from this
spectrum when the renal pedicle was occluded. Most other
published in vivo studies have been far from "non-invasive."
Despite this, the true potential of 31P NMR in clinical nephrol-
ogy can be assessed readily, which will be briefly discussed
below.
Intact kidney in vivo: renal preservation [16, 25, 44, 491.
Observations made on isolated tissues or organs gave the
impetus to the development of new techniques for obtaining
high resolution in vivo NMR measurements. The first approach
was to introduce the radiofrequency coil by surgery around the
organ of interest in anesthetized animals. This method was used
to obtain 31P NMR spectra of rat kidney in vivo [161 to study the
mechanisms of cold and warm ischemic injury during kidney
preservation for transplantation.
A typical 31P NMR spectrum of kidney in vivo shows three
signals corresponding to the , f3, and yphosphates of ATP and
signals for sugar phosphate, Pi, and glycerophosphorylcholine.
An additional resonance of blood, 2,3-diphosphoglycerate dis-
tinguishes this spectrum from the blood-free perfused kidney.
Ischemia caused the disappearance of the AlP signals and
increase in the intensity and a shift in the frequency of the Pi
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the predictable effect of reducing [ATPI to zero, increasing [P1],
and reducing intrarenal pH to 6.5 or lower. These changes have
been observed with indwelling solenoid coils, implanted
chronic coils, and with surface coils 124—26, 49, 50]. ADP was
not observed in NMR spectra of the ischemic kidneys. A
quantitative 31P NMR study by Stubbs, Freeman, and Ross [61
documents the fate of ATP hydrolyzed during renal ischemia:
ATP (6.3 moles) hydrolyzed yielded 24 moles Pi and no
ADP. However, when these findings were compared with
chemical assay, 5.4 jmoles ATP hydrolyzed yielded 3.2 zmoles
of ADP and 44 moles Pi. It is clear that NMR detects only a
fraction (about 50%) of the Pi within the ischemic kidney and
virtually none of the ADP. Furthermore, between 13 to 20
moles of NMR-visible Pi are released from NMR-invisible
percursor(s) during ischemia [6].
31P A/MR iii diagnosis and management of acute renal
fiuilure. The systematic attempt to identify a lesion of energy
metabolism in experimental acute renal failure in rats was
discussed in earlier reviews [3, 41. Studies in seven different
models of acute renal failure indicated that acute changes in
ATP and intrarenal pH could be expected in any model which
used hypoxia or ischemia to induce acute renal failure [251.
Other models of acute renal failure produced by injection of
nephrotoxic chemicals did not have this effect. A more careful
analysis of the data [24, 251 indicates that even these
nephrotoxic agents (mercuric chloride, folate, or uranyl nitrate)
lead to depletion of renal ATP over the course of 3 to 4 hr.
Hypotension developing over this time in the experimental
animal seems to be the most likely explanation. However, it
cannot be excluded that even in these purely "toxic" models of
acute tubular necrosis, depletion of renal ATP may play a
causative role. If depletion of ATP is important in this condi-
tion, then 'P NMR lends itself as a method of monitoring
therapeutic interventions. This has been exploited by Siegal et
al [26] who used it to follow the increase in intrarenal ATP
which occurs when rats are treated with intravenous infusion of
MgClATP.
An alternative theory of renal damage in acute renal failure
implicates the severe intracellular acidosis which has been
observed in those models in which ischemia was used to
produce the syndrome [25, 501. Indeed, renal tubular function
appears to suffer severely as extracellular pH falls in the
experimental setting of the perfused kidney [SI]. Dissociating
the effects of ATP depletion from those of H +accumulation has
been difficult. NMR studies, however, suggest that depletion of
ATP, by fructose infusion for example, can be severe, but does
not cause acute tubular necrosis [25]. There is little doubt that
31P NMR will have an important place in the identification of
some forms of clinical acute tubular necrosis.
Quantitative renal 31P NMR studies have been conducted in a
semiquantitative manner, but relative concentrations of metab-
olites during the course of a study in vivo can be quite adequate.
However, there is much to be learned concerning renal metab-
olism from a more rigorous quantitative approach. As discussed
earlier, this requires an external standard and a pulse interval
which avoids saturating the NMR signal. In consequence, such
studies are almost inevitably much slower. However, because
they form the basis of saturation transfer studies, this drawback
has been acceptable.
Although [ATP] by NMR is equivalent to enzymatic assays
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Fig. 6. Normoihermic pe,fusion (37°) of intact human kidney. Full
metabolic activity was restored to the kidney when perfused with
blood, substrate, and oxygenated medium. Spectrum in the top may be
compared with Figure I. Hypoxia resulted in the loss of high energy
metabolites (middle panel), which were almost fully restored with the
resumption of oxygen supply (bottom pane!). Peaks from left to right
are: unknown (including AMP and sugar phosphate), Pi,
?glycerophosphorylcholine, (PCr), y-ATP, a-ATP, and /3-ATP. See
Figure 1 for further details.
signal. The intracellular pH after 60 mm ofischemia at 37°C was
6.65 0.07 (N = 7). As expected, even at a low temperature
(0°C), ATP was depleted by 15 mm of cold ischemia. Sequential
changes were obtained every 15 mm for 2 hr, and then hourly
for 24 hr postischemia. At 37°C the pH decreased by 0.45 U in
60 to 70 mm, while at 0°C a decrease in pH of 0.45 U was
measured only after some 20 to 24 hr [161.
The fall in pH with prolonged ischemia could be blunted by
flushing the kidney with a solution of suitable pK and capacity
of numerous buffers, agents used for kidney preservation in
clinical practice [23, 49]; the most effective was the divalent
buffer, Bis-tris propane (100 mmoles/liter, pH 7.6 at 37°C and
7.8 at 0°C). Introduced at the onset of ischemia and a pH which
optimized its buffering capacity, the buffer prevented a fall in
pH from 0.7 U in control animals to 0.4 U. It has subsequently
been demonstrated that decreasing the fall in pH by prior buffer
flushing preserves function in the isolated kidney [23].
Effects of renal ischemia. Occlusion of the renal artery has
Nuclear magnetic resonance 139
on the freeze-clamped kidney from a normal rat, there appears
to be a discrepancy in thyrotoxic rats [91 in which much lower
ATP values are obtained in freeze-clamped tissue. It is possible
that at the much increased metabolic rate, ATP is lost even with
rapid freezing of the tissue, in which case in vivo 31P NMR may
have special advantages.
Pi and ADP yield very different results quantitatively as has
been discussed for the perfused rat kidney. While some 25% of
Pi remains visible to NMR, virtually no ADP can be detected by
NMR in the intact kidney in vivo. Whether the ADP which is
observed in spectra of perfused kidney [7] is an artefact of
relatively hypoxic perfusion, or whether it reflects differences
in coil design such that a greater proportion of renal medulla is
observed, remains to be established. Overall, phosphorylation
potential of the kidney is even greater in vivo than that
observed in the perfused kidney. Accordingly, free energy of
ATP hydrolysis is yet higher than has been discussed.
Application(s) of STNMR to kidney in vivo [28—30, 50, 52]. In
the long-term aim of determining renal metabolic rate in hu-
mans, the technique of STNMR has been developed first in the
perfused rat kidney and recently in rat kidneys in vivo, Irradi-
ation of y-P of ATP results in vivo as in the perfused kidney, in
a systematic and reproducible transfer of magnetization to Pi.
With this technique, the rate of ATP synthesis in vivo has been
calculated as 8.9 jmoles/min/g, a value which is only about 60%
of that found in the isolated perfused kidney by the same
technique. However, the oxygen consumption of the kidney
determined in vivo was also somewhat lower with an ATP:oxy-
gen ratio of 1.7. Within the limits of error, this represents
satisfactory measurements of ATP synthesis by STNMR with a
tissue in which the major respiratory fuel in vivo is lipid
(ATP:oxygen = 2), which is thought to be the case for the
kidney.
Renal metabolism in hypotension. Freeman et al [52] ex-
tended the study of renal metabolic rate in vivo to a fundamen-
tal question of renal energy metabolism. If renal oxygen con-
sumption is comprised of energy required for the maintenance
of nontransport functions and for Na reabsorption [53], then
what rate of ATP synthesis is required to maintain a normal
ATP in the absence of Na reabsorption? Because a fall in GFR
secondary to a fall in renal blood flow is a common event in
hypotensive shock, an answer to this question would give a clue
as to whether the basal oxygen consumption can protect the
kidney from ATP depletion. When systemic blood pressure was
reduced by hemorrhage from 120 to 65 mm Hg in the rat,
STNMR detected a 70% fall in the rate of ATP synthesis (8.9 to
3.0 tmoles/min), This is approximately the difference between
normal and basal oxygen consumption discussed by Kramer
and Deetjen [53]. Nevertheless, in the hypotensive rat, ATP
concentration fell significantly from 2,2 to 0.9 Lmoles/g. It
appears that under the conditions of this study, "basal" oxygen
consumption is insufficient to maintain a "normal" ATP con-
centration in the presence of markedly reduced GFR and hence
Na reabsorption. Not only is this finding consistent with the
view of the kidney as an organ 'at the brink of anoxia" [27],
but, since a drop in ATP concentration may itself result in renal
damage, these results may indicate the existence of a prodromal
phase to acute renal failure. If so, then the determination of
renal metabolic rate in vivo by STNMR may offer a very early
acute renal failure detection.
In more recent studies designed to examine this point further
(Ratcliffe, Moonen, Holloway, Leingham, and Radda, unpub-
lished observations), anesthetized rats were examined by 31P
NMR in the 20-cm bore TMR magnet. This permits the animals
to be held in a more "physiological" horizontal posture. Not
surprisingly, blood pressure could be lowered further without
changing [ATPI. However, no measurements of renal metabolic
rate were available to correlate the early drop in GFR, Na
reabsorption, and unchanged energy state during hemorrhagic
hypotension in the system. A complete answer to the question
requires in vivo STNMR.
Proton and sodium imaging by NMR in vivo
For completeness, the now well developed use of proton
NMR for clinical imaging of the kidney [32, 33] should be
mentioned in this review, although biochemical information
from this direction has been slight. There is a clear difference in
T1 relaxation properties between renal cortex and medulla. This
changes during renal venous occlusion [31] but not during renal
ischemia. Many anatomical lesions can be detected readily by
this imaging technique.
While spectroscopic methods permit the enormous "water"
and lipid peaks to be obliterated leaving the chemically impor-
tant resonances of organic chemicals [54], novel pulse se-
quences and decoupling techniques have been applied recently
to the rat brain in vivo [55] and muscle [56]. These techniques
permit nondestructive determination of tissue lactate, amino
acids, and other organic molecules; their applications to renal
biochemistry can then be anticipated.
A further nucleus, the concentration of which is adequate to
allow mapping by NMR, is sodium. To date, only the brain has
been studied, but there would be a good reason to expect that
corticomedullary sodium gradients would lend themselves to
analysis in vivo by this technique.
Summary
31P NMR as a descriptive technique is of interest to nephrolo-
gists. Particular contributions of 31P NMR to our understanding
of renal function may be enumerated.:
• "Free" metabolite levels are different from those classi-
cally accepted; in particular, ADP and Pi are low with implica-
tions for the control of renal metabolism and Pi transport, and,
via the phosphorylation potential, for Na transport.
• Renal pH is heterogeneous; between cortex, outer me-
dulla, and papilla, and between cell and lumen, a large pH
gradient exists. Also, quantitation between cytosol and
mitochondrion of the pH gradient is now feasible.
• In acute renal failure of either ischemic or nonischemic
origin, both ATP depletion and acidification of the renal cell
result in damage, with increasing evidence for the importance of
the latter. Measurements of renal metabolic rate in vivo suggest
the existence of a prodromal phase of acute renal failure, which
could lead to its detection at an earlier and possibly reversible
stage.
• Human renal cancers show a unique 31P NMR spectrum
and a very acidic environment, Cancer chemotherapy may alter
this and detection of such changes with NMR offers a method of
therapeutic monitoring with significance beyond nephrology.
• Renal cortex and medulla have a different T1 relaxation
time, possibly due to differences in lipid composition.
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• It seems that NMR spectroscopy has much to offer to the
future understanding of the relationship between renal bio-
chemistry and function.
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